Activity of an Enzyme Converting Single-Chain Tissue-Type Plasminogen Activator to the Two-Chain Form in Preovulatory Human Follicular Fluid

Molecular Reproduction and Development

Volumn 67, Issue 2, 2004, Pages 178-185

  Ohnishi, Junji ^a   Yokota, Jyunko ^a   Rajapakse, R G S C ^a   Ohnishi, Eriko ^a   Kudo, Takayuki ^b,c   Wada, Shin Ichiro ^b   Takahashi, Takayuki ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c HAKODATE CENTRAL GENERAL HOSPITAL   (Japan)

Author keywords

Follicular fluid; Human ovary; sctPA converting enzyme; tPA plasmin system

Indexed keywords

ALPHA 2 MACROGLOBULIN; ANTIPAIN; APROTININ; ARGININE; BENZAMIDINE; CHORIONIC GONADOTROPIN; HUMAN MENOPAUSAL GONADOTROPIN; LEUPEPTIN; LIMABEAN TRYPSIN INHIBITOR; PLASMIN; PLASMINOGEN; SERINE PROTEINASE; SOYBEAN TRYPSIN INHIBITOR; SYNTHETIC PEPTIDE; TISSUE PLASMINOGEN ACTIVATOR; TRYPSIN INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PURIFICATION; FEMALE; GEL FILTRATION; HUMAN; HUMAN TISSUE; MOLECULAR WEIGHT; OVARY FOLLICLE FLUID; OVULATION; PRIORITY JOURNAL;

EID: 0346728812     PISSN: 1040452X     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrd.10393     Document Type: Article

References (27)

1. Andreasen PA, Egelund R, Petersen HH. 2000. The plasminogen activation system in tumor growth, invasion, and metastasis. Cell Mol Life Sci 57:25-40.
2. Barrett AJ. 1980. Fluorimetric assays for cathepsin B and cathepsin H with methylcoumarylamide substrates. Biochem J 75:731-741.
3. Beers WH. 1975. Follicular plasminogen and plasminogen activator and the effect of plasmin on ovarian follicle wall. Cell 6:376-386.
4. Beers WH, Strickland S, Reich E. 1975. Ovarian plasminogen activator: Relationship to ovulation and hormonal regulation. Cell 6:387-394.
5. Bugge TH, Flick MJ, Daugherty CC, Degen JL. 1995. Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction. Genes Dev 9:794-807.
6. Carmeliet P, Schoonjans L, Kieckens L, Ream B, Degen J, Bronson R, DeVos R, van den Oord JJ, Collen D, Mulligan RC. 1994. Physiological consequence of loss of plasminogen activator gene function in mice. Nature 368:419-424.
7. Collen D, Lijnen HR. 1991. Basic and clinical aspects of fibrinolysis and thrombolysis. 78:3114-3124.
8. Dano K, Andreasen PA, Grondahl-Hansen K, Kristensen P, Nielsen LS, Skriver L. 1985. Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res 44:139-266.
9. Heimark RL, Davie EW. 1980. Bovine and human plasma prekallikrein. Methods Enzymol 80:157-172.
10. Heussen C, Dowdle EB. 1980. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal Biochem 102: 196-2-2.
11. Ichnose A, Kisiel W, Fujikawa K. 1984. Proteolytic activation of tissue plasminogen activator by plasma and tissue enzymes. FEBS Lett 175:412-418.
12. Kato H, Adachi Y, Ohno S, Iwanaga S, Takada K, Sakakibara S. 1980. New fluorogenic peptide substrates for plasmin. J Biochem 88:183-190.
13. Kihara T, Kimura A, Moriyama A, Ohkubo I, Takahashi T. 2000. Identification of components of the intrafollicular bradykinin-producing system in the porcine ovary. Biol Reprod 62:1160-1167.
14. Kimura A, Kihara T, Okimura H, Hamabata T, Ohnishi J, Moriyama A, Takahashi K, Takahashi T. 2000. Identification of porcine follipsin as plasma kallikrein, and its possible involvement in the production of bradykinin within the follicles of porcine ovaries. Mol Reprod Develop 57:79-87.
15. Kudo T, Ohnishi J, Murata M, Wada S, Yoshida H, Fujimoto S, Takahashi T. 1997. An isoform of plasma kallikrein occurring in the follicular fluid of human ovaries. Biomed Res 18:369-374.
16. Leonardsson G, Peng X-R, Liu K, Nordstrom L, Carmeliet P, Mulligan R, Collen D, Ny T. 1995. Ovulation efficiency is reduced in mice that lack plasminogen activator gene function: Functional redundancy among physiological plasminogen activators. Proc Natl Acad Sci USA 92:12446-12450.
17. Matsui H, Ohnishi J, Takahashi T. 1998. Proteolytic activation of tissue-type plasminogen activator by the culture media of mouse cancer cells. Zool Sci 15:499-505.
18. 2-macroglobulin complex isolated from human ovarian follicular fluid. Zool Sci 16:285-290.
19. Murdoch WJ, McDonnel AC. 2002. Role of the ovarian surface epithelium in ovulation and carcinogenesis. Reproduction 123:743-750.
20. Ny T, Wahlber P, Brandstrom IJM. 2002. Matrix remodeling in the ovary: Regulation and functional role of the plasminogen activator and matrix metalloproteinase systems. Mol Cell Endocr 187: 29-38.
21. Ohnishi J, Murata M, Kohyama K, Yoshida H, Wada S, Mikinoda S, Fujimoto S, Takahashi T. 1997. Follicular fluid from human ovaries contains plasma kallikrein in free and in complex with α2-macroglobulin. Biomed Res 18:161-170.
22. Reich R, Miskin R, Tsafriri A. 1986. Intrafollicular distribution of plasminogen activators and their hormonal regula[t]ion in vitro. Endocrinology 119:1588-1593.
23. Stubbs MT, Renatus M, Bode W. 1998. An active zymogen: Unraveling the mystery of tissue-type plasminogen activator. Biol Chem 379:95-103.
24. Tsafriri A, Dekel N. 1994. Molecular mechanism in ovulation. In: Findlay JK, editor. Molecular biology of the female reproductive system. San Diego: Academic Press. pp 207-258.
25. 2-antitrypsin. Endocrinology 124:415-421.
26. Wada S, Kudo T, Kudo M, Sakuragi N, Hareyama H, Nishihira J, Fujimoto S. 1997. Induction of macrophage migration inhibitory factor in human ovary by human chorionic gonadotrophin. Hum Reprod 14:395-399.
27. Yousef GM, Diamandis EP. 2001. The new human tissue kallikrein gene family: Structure, function, and association to disease. Endocr Rev 22:184-204.